Personalis Other Operating Income or Expenses 2018-2024 | PSNL
Personalis other operating income or expenses from 2018 to 2024. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
Personalis Annual Other Operating Income or Expenses (Millions of US $) |
2023 |
$-14 |
2022 |
$ |
2021 |
$ |
2020 |
$ |
2019 |
$ |
2018 |
$ |
2017 |
$ |
Personalis Quarterly Other Operating Income or Expenses (Millions of US $) |
2024-06-30 |
|
2024-03-31 |
|
2023-12-31 |
$-4 |
2023-09-30 |
$-6 |
2023-06-30 |
$-0 |
2023-03-31 |
$-4 |
2022-12-31 |
|
2022-09-30 |
|
2022-06-30 |
|
2022-03-31 |
|
2021-12-31 |
|
2021-09-30 |
|
2021-06-30 |
|
2021-03-31 |
|
2020-12-31 |
|
2020-09-30 |
|
2020-06-30 |
|
2020-03-31 |
|
2019-12-31 |
|
2019-09-30 |
|
2019-06-30 |
|
2019-03-31 |
|
2018-12-31 |
|
2018-09-30 |
|
2018-06-30 |
|
2017-12-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$0.278B |
$0.073B |
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
|